Abstract Cognition is often affected in a variety of neuropsychiatric, neurological, and neurodevelopmental disorders. The neural discriminative response, reflected in mismatch negativity (MMN) and its magnetoencephalographic equivalent (MMNm), has been used as a tool to study a variety of disorders involving auditory cognition. MMN/MMNm is an involuntary brain response to auditory change or, more generally, to pattern regularity violation. For a number of disorders, MMN/MMNm amplitude to sound deviance has been shown to be attenuated or the peak-latency of the component prolonged compared to controls. This general finding suggests that while not serving as a specific marker to any particular disorder, MMN may be useful for understanding factors of cognition in various disorders, and has potential to serve as an indicator of risk. This review presents a brief history of the MMN, followed by a description of how MMN has been used to index auditory processing capability in a range of neuropsychiatric, neurological, and neurodevelopmental disorders. Finally, we suggest future directions for research to further enhance our understanding of the neural substrate of deviance detection that could lead to improvements in the use of MMN as a clinical tool.
Introduction
The mismatch negativity (MMN) component of eventrelated brain potentials (ERPs) has become a very popular tool to study auditory functions. The MMN measure enables one to gain insights into the neurobiological substrate of central auditory processing, particularly into auditory memory, as well as into various attention-related processes controlling the access of auditory input to conscious perception and higher forms of memory (Näätänen et al. 2011a (Näätänen et al. , 2012 Sussman 2007; Sussman et al. 2013) . MMN paradigms are being used to address a growing range of clinical questions, which is increasing our understanding of disease mechanisms of major neuropsychiatric, neurological, and neurodevelopmental disorders. The focus of this review is on providing an understanding of how MMN amplitude and latency may be used in clinical applications to index cognitive dysfunction. We first provide a brief history of the MMN, followed by a review of studies that have used MMN to examine auditory processing in a range of neuropsychiatric, neurological, and neurodevelopmental disorders. The final section suggests directions that MMN research can take to address clinical questions related to adult and childhood disorders involving auditory cognition.
What is the MMN?
The auditory MMN is a memory-based change-detection brain response to any discriminable change in a stream of auditory stimulation, including abstract-type changes (automatically detected by the brain), such as detection of a violation of a multi-stimulus pattern regularity (Sussman et al. 1998 (Sussman et al. , 1999 Tervaniemi et al. 1994; Schröger et al. 1994) or a rule (e.g., Saarinen et al. 1992; Paavilainen et al. 2007; Paavilainen 2013) derived from the recent auditory stimulation. The capability of MMN to index violations of abstractions from sequential patterns (e.g., rising vs. falling pitch or trajectory) indicates a link between automatic processes and higher-level cognitive functions at the level of auditory cortex. This gives rise to the concept of a primitive sensory intelligence, with substantial complex auditory analysis occurring outside the focus of perception (for reviews, see Näätänen et al. 2001 Näätänen et al. , 2007 Näätänen et al. , 2010 Näätä-nen 2001) . Studies have shown that MMN is a vital tool that can be used for understanding more complex calculations of the auditory input. These investigations currently form an intense research focus in the field (Bakker et al. 2013; Bendixen et al. 2008 Bendixen et al. , 2012 Bendixen et al. , 2014 Besle et al. 2013; Bonte et al. 2005; Caclin et al. 2006; Chen and Sussman 2013; Colin et al. 2002; Cornella et al. 2012; Dyson et al. 2005; Grimm and Escera 2012; Herholz et al. 2009; Jacobsen et al. 2013; Koelsch 2009; Liu and Holt 2011; MacDonald and Campbell 2011; Müller et al. 2005; Nager et al. 2003; Paavilainen et al. 2007; Peter et al. 2012; Pulvermüller et al. 2008; Rahne and Sussman 2009; Salisbury 2012; Schechtman et al. 2012; Sculthorpe et al. 2009; Shtyrov et al. 2003; Sonnadara et al. 2006; Steinberg et al. 2010; Sussman et al. 1998 Sussman et al. , 1999 Sussman et al. , 2007 Sussman 2005; Todd and Robinson 2010; van Zuijen et al. 2005; Wacongne et al. 2012; Weise et al. 2012; Zion-Golumbic et al. 2007 ). Due to its ability to automatically index violations within complex auditory scenes, the MMN is now more often characterized in terms of a regularity-violation response rather than just as a sound-change response Sussman 2007; Winkler 2007; Sussman et al. 2013) .
To understand the place of the MMN in a wider context of the functioning of the organism, it is important to consider what the auditory sensory system must accomplish to provide useful neural representations of the sound sources in the environment. First, the system must generate representations of the stimulus input, providing memory traces that represent the original sources, and the regularities derived from them. Secondly, the system must continuously up-date the representations to maintain the integrity of the ongoing sources (Rahne et al. 2007; Sussman and Steinschneider 2006; Sussman and Winkler 2001; Winkler et al. 1996) . There has been a recent postulation that the processes indexed by MMN involve anticipation of the forthcoming representations of the immediate future (Näätänen et al. 2010; Bendixen et al. 2014; Lieder et al. 2013; Pieszek et al. 2013; Rohrmeier and Koelsch 2012; Winkler and Czigler 2012; Todd and Mullens 2011; Chennu et al. 2013; Garrido et al. 2008 ). Näätänen and colleagues have postulated that this sensory updating has a high-priority access to frontal mechanisms of attentional control, explaining the rapid involuntary attention-switch to stimulus change (for a review, see Näätänen et al. 2011a, b; Opitz et al. 2002; Rinne et al. 2006) .
One might wonder why the MMN was reported as early as the end of the 1970s while cognitive neuroscience research using the MMN (and MMNm) measure has only recently intensified, as evidenced by more than 3,000 refereed English-language scientific articles using, or referring to, MMN. Furthermore, six major international congresses have already been dedicated to the MMN and its different applications, with the sixth, held in New York in May 2012 and culminating in the present Special Issue. This delay may be due to the strong cognitive Zeitgeist that prevailed in the field of cognitive neuroscience in the 1960s and 1970s, and may have had a biasing effect on cognitive brain research. Viewed against this background, an involuntary discrimination process between two very similar stimuli occurring in the absence of attention, and hence outside the conscious mind was received with skepticism. It was rather thought that such fine-grained discrimination processes could occur only when supported by attention and voluntary effort (Woldorff et al. 1991) .
A second reason for the relatively late emergence of research using MMN is that in active oddball paradigms, there can be overlap with other ERP components, most notably the N1 component (May and Tiitinen 2010) , and the N2 target detection component (Näätänen et al. 1978; Näätänen 1975) . Methods developed to isolate the MMN from these two components included subtracting the standard ERP from the deviant ERP waveforms (Ford et al. 1976; Simson et al. 1976 Simson et al. , 1977 Squires et al. 1975 Squires et al. , 1976 and examining the topographical distribution (Alho 1995). The ''N2'' was divided into an earlier ''automatic'' MMN component (originally called the ''N2a'') and a later attention-dependent ''N2b'' component (Näätänen et al. 1978 (Näätänen et al. , 1982 Näätänen and Michie 1979) . The N2b response has been noted to have a more central scalp distribution than the MMN (Alho 1995), and MMN shows a clear polarity inversion for simple tone feature deviants at sites inferior to auditory cortices when a nose reference is used. Figure 1 displays a schematic illustration of the different ERP components evoked in the auditory oddball paradigm during active detection of the oddball stimulus.
A third reason why research using the MMN measure has become more popular for cognitive neuroscience research is that it has become clear that MMN can be used to study listeners' processing of complex auditory scenes (e.g., Sussman et al. 1998 Sussman et al. , 1999 Sussman et al. , 2005 Sussman et al. , 2007 Colin et al. 2002; Sussman 2005) , speech discrimination as it pertains to categorical perception (e.g., Aaltonen et al. 1997; Sharma et al. 1993; Maiste et al. 1995; Sandridge and Boothroyd 1996; Sharma and Dorman 1998; Bradlow et al. 1999) and to native-language experience (e.g., Näätänen et al. 1997; Winkler et al. 1999; Phillips et al. 1995; Dehaene-Lambertz 1997; Dehaene-Lambertz et al. 2000; Shafer et al. 2004) . These advances in research demonstrated the utility of the MMN measure for use in a wide range of scientific and clinical applications. The clinical application of MMN flourished in particular because relative complex brain functions could be examined in the absence of complicated active behavior on the part of the participant. Because MMN can be elicited passively, it can be recorded from behaviorally and cognitively impaired subjects, providing an accurate functional measure of local and distributed cortical processing.
Several early studies showed that one could predict behavioral discrimination accuracy by the sensitivity of the MMN response to small stimulus changes. This was first shown by Lang et al. (1990) , who found that the accuracy of the behavioral discrimination of a frequency difference between a pair of short tone pips presented in close succession strongly correlated with the MMN amplitude for frequency change recorded in a separate, passive session (Lang et al. 1990 ). Moreover, a large number of subsequent studies showed that with the MMN, one could monitor the improvement in sound discrimination as a function of practice, both for linguistic stimuli (Cheour et al. 2002; Kraus et al. 1995; Tremblay et al. 1997; Winkler et al. 1999 ) and non-linguistic stimuli (Näätänen et al. 1993; Tervaniemi et al. 2001 ). In addition, several studies showed that ''musical'' subjects tended to be more sensitive to changes along different musically-important dimensions, which were also indexed by MMN (Brattico et al. 2001 (Brattico et al. , 2009 Garza Villarreal et al. 2011; Koelsch et al. 1999; Seppänen et al. 2007; Tervaniemi et al. 2006; van Zuijen et al. 2004 van Zuijen et al. , 2005 . These various studies suggest that the MMN provides a level of assessment of auditory discrimination ability, as well as an index of improvement in discrimination ability with training or exposure to certain stimulation. Previously, in the absence of attention or a behavioral task, ERPs and other physiological responses appeared to provide only an objective index of whether the central auditory system of a person detected the presence of acoustic stimulus energy, but not whether sounds could also be discriminated (for objective ERP audiometry, see Rapin et al. 1966 ). Hence, a patient could have a ''normal'' ERP response to auditory input but nevertheless could have impaired speech-sound perception in the mother-tongue (Ilvonen et al. 2004) . Consequently, finding a significant relationship between MMN and an individual's ability to perceptually discriminate a sound contrast without attending to the sounds or performing a task with them was notable. These studies demonstrating modulation of MMN amplitude and latency with learning provide an important link between perceptual processes and the sound detection mechanism indexed by MMN. This has been profitably utilized in the assessment of training programs, as described below for example, in individuals with specific language impairment (SLI).
It is important to recognize that behavioral perception and MMN measures of discrimination are complementary, rather than redundant. Clearly there is a relationship between neural discrimination as indexed by the MMN and sound perception indexed by behavioral measures. However, there has been some discrepancy among studies, in that the relationship between behavior and the MMN measure is not always significantly correlated for tone features (e.g., cf. Chen and Sussman 2013; Horváth et al. 2008) and for speech sounds. In studies of speech processing, this is particularly enigmatic, with numerous studies providing evidence of behavioral discrimination for difficult speech contrasts (e.g., Hindi dental and retroflexed consonants) with no MMN elicitation to those contrasts, even for speakers for whom the contrast is native (e.g., Shafer et al. 2004 ). The disparate findings of these studies suggest that MMN may be indexing the earlier acousticphonetic components of the speech and not the effects of categorical perception (Dalebout and Stack 1999; Sussman et al. 2004; Sussman 2005) . Overall, these findings do not detract from the utility of the MMN measure for studying cognitive aspects of auditory processing, but rather highlight the importance of understanding the benefits and limitations of MMN, which will allow for maximizing its utility in basic and clinical applications (see Sussman et al. 2013 ).
Neuropsychiatric and Neurological Disorders
There is considerable evidence for MMN differences in various neuropsychiatric and neurological disorders. We will briefly review these studies and consider potential mechanisms for the deficits in auditory processing revealed by MMN/MMNm.
Schizophrenia
Studies of schizophrenia have consistently reported attenuated MMN amplitudes to auditory contrasts compared to normal controls (Ford and Mathalon 2012; Shelley et al. 1991; Javitt 2010; Baldeweg et al. 2004; Baker et al. 2005; Umbricht and Krljes 2005; Kayser et al. 2014; Rissling et al. 2013; Salisbury et al. 2002 Salisbury et al. , 2007 . The 'deficits' in MMN have been associated with deficits in auditory discrimination at the behavioral level (Javitt et al. 1995) , and with poor social/occupational and executive functioning (Kawakubo et al. 2007; Oades et al. 2006 ; for a recent review, see Kaur et al. 2011) . Moreover, Light and Braff (2005a) found a strong association between the MMN measure of auditory discrimination and ratings on the global assessment of functioning (a rating of social, psychological, and occupational life functions), but no correlation with positive and negative symptoms. Some studies have suggested that the greater the MMN deficit, the weaker the cognitive or functional status of the patients (also Light and Braff 2005b; Baldeweg et al. 2004; Kawakubo et al. 2007; Kiang et al. 2007; Hermens et al. 2010; Kaur et al. 2013) .
The first studies reporting an auditory deficit in patients with schizophrenia, at the level indexed by MMN, were those of Shelley et al. (1991) who found a deficit for toneduration increment discrimination, and Javitt et al. (1993) who observed a frequency-discrimination deficit in schizophrenia. Since these pioneering findings, the volume of research that has used the MMN/MMNm measure to elucidate auditory processing in schizophrenia has grown tremendously. For example, Thompson Reuters Science Citation Index currently includes more than 200 ''Mismatch Negativity and Schizophrenia'' Medline-referenced articles.
Although MMN is greatly reduced in schizophrenia within the first few years after first hospitalization for psychosis, it is not entirely clear whether MMN is reduced at or before first psychosis (Salisbury et al. 2002) . Salisbury et al. reported that MMN to frequency deviants was not impaired at the first hospitalization for schizophrenia (also Magno et al. 2008; Devrim-Ü çok et al. 2008) . Similarly, Umbricht et al. (2006) demonstrated, on average, a relatively normal MMN in first-hospitalized patients to duration deviants compared to healthy controls. However, those first-episode schizophrenia patients with poor social functioning and low educational attainment had reduced MMNs compared to controls (Umbricht et al. 2006) . In contrast, several papers have reported reduced MMN at first episode of psychosis in either mixed psychosis (schizophrenia and bipolar disorder, BD) or schizophrenia (Hermens et al. 2010; Kaur et al. 2011; Atkinson et al. 2012; Nagai et al. 2013 ). However, results from Umbricht et al. (2006) indicate that a difference in findings for first episode patients across studies may be, at least in part, due to whether or not patients were assessed according to premorbid IQs in psychosis groups. In studies in which experimental groups were matched for intellectual functioning, and followed longitudinally, MMN was not reduced at first episode, but became so during the early course of the disease (Kaur et al. 2013 ). There have also been differential findings for frequency and duration MMN at first episode, with some findings suggesting that duration MMN may reflect greater sensitivity to a first psychotic break than frequency MMN (Nagai et al. 2013) . Kaur et al. also demonstrated that the greatest MMN deficits at follow-up testing were associated with the greatest impairments at first testing.
Although the findings of MMN reductions at first episode for psychosis are, at best, equivocal, several groups have examined whether reductions of MMN amplitude could serve as a biomarker for incipient psychosis in the schizophrenia prodrome, before florid psychosis has emerged. Brockhaus-Dumke et al. (2005) failed to detect any group mean MMN differences to frequency or duration deviants in prodromal subjects, but did not assess whether there was a subset of prodromal subjects with abnormal MMNs that later converted to schizophrenia. Bodatsch et al. (2011) found that those subjects who converted to psychosis during a follow-up period of 2 years had considerably smaller MMN amplitudes to tone-duration increments at baseline, and this reduced MMN amplitude was comparable to that in first-episode patients. In contrast, subjects who did not convert to psychosis had MMN amplitudes comparable to that of healthy, age-matched controls. These results were subsequently corroborated (Atkinson et al. 2012; Higuchi et al. 2013; Kayser et al. 2014; Shaikh et al. 2012) . Still, several reports have found no difference in frequency or duration MMN amplitudes between at-risk prodromal subjects and controls (Nagai et al. 2013 for review). Thus, although those who convert to psychosis may show reduced MMN amplitudes compared to those who do not convert, the effect size may be relatively small.
Recently, Perez et al. (2014b) compared amplitudes evoked by single and double deviant duration and frequency MMNs in high-risk individuals compared to early illness schizophrenia patients. They reported reduced MMN in those individuals who converted to psychosis compared to those that didn't convert, and additionally showed that the MMN amplitude evoked by double deviants amplitude (but not single duration or frequency MMNs) predicted the time lag to onset of psychosis in high-risk individuals (for reviews, Belger et al. 2012; Light and Näätänen 2013; Nagai et al. 2013; Perez et al. 2014a ). These exciting findings indicate the potential for MMN to serve as an indicator of individuals at risk who are most likely to convert to psychosis. Recent research has also shown that adolescents recruited from the general population who show some psychotic symptoms tend to show attenuated MMN amplitudes to tone duration increments (Murphy et al. 2013) , which suggests that the combination of some psychotic symptoms (but not sufficient for a clinical diagnosis) and a reduction in duration-MMN amplitude could serve as an indicator of risk-of-illness long before illness onset. Early interventions in individuals who are likely to experience psychosis in the near (or far) future may prevent, or at least delay the transition to psychosis. Thus the finding of improved prediction of psychosis by the inclusion of auditory function assessment via MMN is promising (Kaur et al. 2013; Umbricht et al. 2002) .
Although the neural pathophysiology giving rise to schizophrenia remains unclear, recent theories suggest an imbalance in Glu and GABA. For example, lamotrigine (an anti-convulsant) reduces Glu and blocks ketamine-induced psychosis. One leading candidate mechanism for this imbalance in schizophrenia is dysfunction in synaptic plasticity via the N-methyl-D-aspartate (NMDA) receptor Javitt 2000 Javitt , 2010 Javitt , 2012 Krystal et al. 2003) . The NMDA receptor and its glycine binding site play a crucial role in long term potentiation, long term depression, and synaptic plasticity. Importantly, it has been found that MMN elicitation is sensitive to activity at the NMDA receptor. In monkeys, administration of NMDA antagonists led to a reduction in the MMN response, but no change to the initial sensory evoked responses (e.g., the N1 component, Javitt et al. 1996; Javitt 2000) . In humans, administration of psychotomimetic drugs that act on the NMDA receptor led to a reduction of the MMN (Umbricht et al. 2000) . Thus, MMN may serve as an index of function within a neural circuit that depends on a particular type of interneuronal communication and processing thought to be abnormal in schizophrenia, namely NMDA-mediated dendritic plasticity.
Thus, MMN may be a particularly good index of the underlying cortical pathophysiology in schizophrenia, and may be useful as an indicator for new pharmacological therapy (Lavoie et al. 2008 ). For example, N-acetyl-cysteine (NAC), is a glutathione precursor that not only acts as an antioxidant to counter the NMDA-mediated superoxide oxidative stress reaction, but is the essential building block of both Glu and GABA, and thus can potentiate the activity of the NMDA receptors. In a 6-week administration of NAC, patients showed increased MMN amplitude to a tone-frequency change (Lavoie et al. 2008 ). This suggests that a factor contributing to the attenuated MMN response in schizophrenic patients may be an NMDA deficit. However, the relationship could also be an indirect one, mediated by some other deficit in auditory function.
Bipolar Disorder (BD)
MMN results in patients with BD have been equivocal (Domján et al. 2012; Umbricht et al. 2003; Salisbury et al. 2007 ). However, compared to schizophrenia, MMN studies on BD are scarce in number (Andersson et al. 2008; Catts et al. 1995; Domján et al. 2012; Hall et al. 2009; Salisbury et al. 2007; Takei et al. 2010; Umbricht et al. 2003) . MMNm peak latencies have been reportedly prolonged for tone-duration increments (Takei et al. 2010) , tone duration decrements (Andersson et al. 2008) , and for frequency changes (Takei et al. 2010 ) in these patients, as well as smaller in amplitude MMN compared to control subjects (Andersson et al. 2008 ). In contrast, shorter peak latency in individuals diagnosed with BD and longer peak latency only in individuals diagnosed with schizophrenia have also been reported (Domján et al. 2012) . MMN findings in patients for first episode BD have been equivocal, as with first-episode schizophrenia. A few studies have shown reduced MMN in first episode bipolar psychosis (Hermens et al. 2010; Kaur et al. 2011 Kaur et al. , 2013 , whereas others have found no reduction in MMN amplitude at first episode bipolar psychosis (Umbricht et al. 2006; Salisbury et al. 2007 ). Some discrepancy between findings for frequency and duration MMN has also been reported. Domján et al. (2012) found, a prolonged MMN peak latency to tonefrequency changes in bipolar patients with a history of psychosis compared to controls, but with no significant group effect for MMN peak latency of tone-duration increments. Reite et al. (2009) observed structural and functional auditory-cortex abnormalities in patients with BD, which was suggested as possibly associated with the cognitive impairments found in these patients (Bruder et al. 1994) . In summary, overall, these findings are somewhat inconclusive regarding whether patients with BDs exhibit deficits in auditory discrimination at the level measured by MMN.
Stroke and Aphasia
Lesions to cortical regions involving speech and language skills often result in significant deficits in communication ability, as well as deficits in related functions such as verbal working memory (Martin et al. 2012 ). Investigations of auditory discrimination using the MMN in patients with acquired aphasia due to cerebral infarct have generally found reduced amplitude or absent MMNs to speech stimuli (Aaltonen et al. 1993; Csépe et al. 2001) . In addition, studies have shown that MMN amplitude significantly correlated with changes in cognitive ability post-stroke (Becker and Reinvang 2007; Ilvonen et al. 2003; Särkämö et al. 2010 ). For example, Ilvonen et al. (2003) found that patients had attenuated MMN amplitudes for tone duration and tone frequency changes to harmonically-rich tones presented to the right ear at 4 and 10 days following onset of left-hemisphere stroke. Recovery was indicated by an increase in MMN amplitudes to the approximate size of unimpaired age-matched controls 3 months following. Speech comprehension test scores also improved during this period. Moreover, these results demonstrated a close relationship between the increase in the duration-MMN amplitude and improvement on the speech-comprehension test from the Boston Diagnostic Aphasia Examination. Another study demonstrating recovery of functions in the 6 months following stroke onset found an increase in MMN amplitude that correlated with behavioral improvements on tasks of verbal memory (Särkämö et al. 2010) . Although the precise mechanism of recovery is not known, some recent literature has suggested that listening to music or enriched auditory environments may facilitate recovery of auditory functions (Särkämö et al. 2008 (Särkämö et al. , 2010 .
MMN has also indexed speech discrimination ability in patients with temporal lobe lesions. Auther et al. (2000) found that the presence of an MMN to speech-sound changes was an indicator of better speech comprehension compared to patients with an absent MMN to the same speech sounds. Pettigrew et al. (2005) also reported a strong correlation between auditory comprehension in patients with aphasia and MMN amplitudes to complextone duration decrement and to syllable changes. Wertz et al. (1998) observed that a clear MMN to a speech-sound change was present in only 54 % of aphasic subjects. They also observed that for patients showing an MMN, its duration was related to severity (as measured by The Western Aphasia Battery, The Porch Index of Communicative Ability, and The Token Test), with shorter duration MMNs being found for more severe cases of aphasia.
These findings indicate potential clinical utility of the MMN as an objective tool for monitoring post stroke recovery and treatment efficacy. This is particularly important in patients with poor cognitive function, in particular poor communicative function, because it can be difficult to obtain reliable behavioral measures that indicate the source of breakdown in function or that can be used to monitor recovery, particularly in more severe cases. More specifically, poor language comprehension and production can interfere with obtaining an accurate measure of auditory discrimination and perception. In addition, MMN can provide a means for understanding the relationship between auditory processing deficits and sensory and cognitive deficits in cases of disorders caused by stroke.
Epilepsy
The few studies of auditory discrimination indexed by MMN in persons with epilepsy have indicated poorer function compared to age-matched controls (Miyajima et al. 2011; Korostenskaja et al. 2010; Liasis et al. 2000) . Korostenskaja et al. (2010) employed the five-features MMN paradigm ) to 13-year-old patients with epilepsy and found that the MMNm amplitude was attenuated for all five of the auditory deviant feature types. However, there has been some discrepancy as to the nature of the poorer auditory function, in particular regarding whether deficits are specific to speech input (Boatman et al. 2008; Rosburg et al. 2005) . MMN has also been used to assess specific post-treatment recovery of function (Borghetti et al. 2007) , as well as to assess the nature of the deficits (Korostenskaja et al. 2010) . Consistent with this, Lin et al. (2007) reported that MMNm was temporally overlapped by a phase-locking response of alpha and theta rhythms, which was especially pronounced in the five patients who subsequently became seizure-free after the successful surgical removal of right temporal epileptic focus.
These findings indicate that the MMN measure can provide information regarding auditory function in patients with epilepsy and can possibly serve as a measure of the status of auditory cognitive function at different phases of recovery and treatment. Additional studies are needed to fully understand how discrimination indexed by MMN in these patients relates to important cognitive functions, such as speech and language and verbal working memory.
Other Neurological Disorders
The MMN has been used as a measure of auditory function in several studies of other neurological disorders. Smaller amplitude MMNs have been observed in patients with multiple sclerosis (Jung et al. 2006; Santos et al. 2006) Parkinson's disease (Pekkonen et al. 1995; Brønnick et al. 2010) , and in elderly participants with dementia compared to healthy normal elderly controls (Schroeder et al. 1995; Mowszowski et al. 2012) . Somewhat smaller MMNs have been found in normal, healthy, elderly participants compared to younger controls (Kisley et al. 2005; Foster et al. 2013) but not to the extent found for clinical disorders such as those individuals with dementia. Conversely, there is indication that in patients with Alzheimer's disease, intact auditory processing is indexed by MMN relative to attention-dependent processing (Gaeta et al. 1999; Vecchio and Määttä 2011) .
Neurodevelopmental Disorders
The MMN measure has been increasingly used to explore the relationship between auditory processing and developmental disorders that show language-learning delays or deficits (e.g., Kemner et al. 1995; Ferri et al. 2003; Lalo et al. 2005; Jing et al. 2006; Dunn et al. 2008; Datta et al. 2010; Gomot et al. 2011) . In addition, a number of recent studies have examined whether the MMN and the mismatch response (MMR) can serve as markers for risk of disorders (Kuhl et al. 2008; Leppänen et al. 1999 Leppänen et al. , 2002 van Leeuwen et al. 2006; van Zuijen et al. 2013) . In infants, the electrophysiological response to deviant stimuli has often been called the MMR (Fig. 2) .
SLI and Developmental Dyslexia (Dyslexia)
SLI and dyslexia are two developmental disorders that have been closely linked to poor auditory processing (Tallal et al. 1993; Bishop 2006 Bishop , 2007 Nittrouer 2012) . These studies have generally revealed poor MMN amplitudes to speech contrasts (Ahmmed et al. 2008; Baker et al. 2005; Bradlow et al. 1999; Datta et al. 2010; Davids et al. 2011; Koelsch et al. 2012; Holopainen et al. 1997; Korpilahti and Lang 1994; Noordenbos et al. 2012; Rinker et al. 2007; Shafer et al. 2005; Stoodley et al. 2006; Uwer et al. 2002) . Reduced amplitude MMN is generally thought to reflect poorer representations of the phonetic categories within the speaker's native language, which may be the result of poor auditory resolution or poor language-specific learning of relevant phonetic cues (e.g., Shafer et al. 2005; Datta et al. 2010) . One study of 6-year-old children at risk for dyslexia, in addition to reduced MMN to phonemic contrasts (e.g., / ba/ vs. /da/) observed larger MMN to a within-category difference (allophonic variants of /ba/) in the at-risk children compared to the matched controls (Noordenbos et al. 2012 ). This finding is consistent with an explanation of poor language-specific learning, since within-category differences should become irrelevant with language learning. Alternatively, it could represent the sensitivity of the MMN to acoustic variation in the speech signal ). The MMN measure can be used to address questions about the relationship between general auditory processing and language deficits in children with dyslexia and SLI (Baldeweg et al. 1999; Benasich et al. 2006; Bishop et al. 2010) .
Autism Spectrum Disorder (ASD)
MMN amplitude and latency differences have also provided insights into auditory processing skills in children with ASD. For example, studies in children with ASD have shown robust, and even enhanced, MMN amplitudes to non-speech stimuli, but attenuated MMN responses to speech stimuli (Oram Cardy et al. 2005; Stoodley et al. 2006; Gomot et al. 2002; Ferri et al. 2003; Ceponiene et al. 2003; Kuhl et al. 2005; Lepistö et al. 2005 Lepistö et al. , 2008 Näätänen and Kujala 2011 ; for a recent review, Kujala et al. 2013) . Roberts et al. (2011) found that in 7-9-year-old children with ASD the MMN peak latency for tone-duration and vowel changes was delayed compared to normally developing age-matched children. Importantly, this delay was considerably increased in duration if the child also suffered from a delay in linguistic development. 
Cleft Palate
The MMN measure has also been used to examine children with cleft palates and/or with Catch-22 syndrome, who are known to have learning difficulties. Children with Catch-22 and cleft palates showed shorter auditory sensory memory compared to typically-developing controls, as indexed by the rapid disappearance of the MMN with the gradual prolongation of the stimulus-onset asynchrony (Cheour et al. 1998) . In another study, children with cleft palates exhibited smaller amplitude MMN than controls (Yang et al. 2012 ).
Acquired Development Disorders
The MMN measure has also been used to evaluate possible damage to central auditory processing associated with acquired developmental deficits. Jansson-Verkasalo et al. (2003, 2004) found that the MMN amplitude elicited by a consonant change at 4 years of age (from conception), obtained in premature infants who had a low birth weight, was considerably smaller than that in age-matched control children. Further, they found that the absence of an MMN at 4-5 years of age significantly predicted naming difficulties when children were 6 years of age. In addition, children with epilepsy also showed attenuated MMN (Boatman et al. 2008; Liasis et al. 2001 ). For example, Boatman et al. (2008) tested a group of 7-11-year-old children with benign rolandic epilepsy, and found that the MMN was absent (or prolonged in latency) to speechsound changes but not to tone changes. Importantly, no group differences in the amplitude or latency of the obligatory N1 component was found for either speech or tones. Moreover, those with no MMN to speech sounds also had the most severe cognitive impairments on behavioral testing. These studies highlight the potential utility of MMN in serving as a clinical biomarker of language risk in developmentally-disordered populations, which is of particular interest in children who are difficult to test using behavioral measures (e.g., non-compliant children with ASD, and atrisk infants and toddlers). MMN shows promise as a clinical measure of auditory and speech processing in children. However, to date, fairly simple auditory stimuli and patterns have been used. Future studies using more complex stimuli and patterns (e.g., similar to Kujala et al. 2005; Lepistö et al. 2008; Bonte et al. 2007 ) could be undertaken to determine whether the sensitivity and specificity of the MMN response can be improved sufficiently for clinical use.
Infants and Early Identification of Risk
One challenge in infant studies is that the negative displacement of the deviant ERP waveform typically identified in the child and adult responses to oddball stimuli as MMN, is observed as a positive displacement in infants (Dehaene-Lambertz and Dehaene 1994; Trainor et al. 2003; Kushnerenko et al. 2007; Morr et al. 2002; Weber et al. 2004 ). This response in infants has been called the positive MMR (Fig. 2) . However, several studies have reported both a positive MMR and a negative MMR. This may be a developmental issue. The negative MMR may be equivalent to the adult MMN (He et al. 2007 (He et al. , 2009 Shafer et al. 2010 Shafer et al. , 2011 . With increasing age, the negative MMR becomes larger in amplitude and earlier in latency (Shafer et al. 2000 Morr et al. 2002) . Concurrently, the positive MMR becomes earlier in latency and decreased in amplitude. By 7 years of age, the positive MMR is no longer present . However, the developmental trajectory may differ in individuals with neurodevelopmental disorders (Ahmmed et al. 2008; Kuhl et al. 2008; Friedrich et al. 2009 ). Kuhl et al. (2008) observed that infants with more negative MMRs to native-language speech sounds showed better language scores as preschoolers (also Friedrich et al. 2009 ). This finding is consistent with the suggestion that increased experience with native language speech sounds results in a stronger neural representation at a preattentive level, supporting automaticity of speech perception. Alternatively, it may be that infants who become better language users are more attentive to speech earlier on. In this latter case, the increased attention to the speech would allow for formation of more robust representations (Shafer et al. 2012) .
Several recent studies suggest that the MMR elicited in infants is predictive of later language outcomes (Leppänen et al. 1999 (Leppänen et al. , 2002 van Leeuwen et al. 2006; van Zuijen et al. 2013 ). In contrast, other studies have been less sanguine about the potential utility of the MMR as a clinical tool (e.g., Benasich et al. 2006; Choudhury and Benasich 2011) , perhaps due to the current lack of clarity in what the MMR reflects in the infant brain. Further studies are needed that examine both stimulus and task factors to elucidate factors contributing to the response, and improve its potential clinical application in infant populations. Nonetheless, these studies clearly establish the utility of using the MMN and MMR measures as research tools for better understanding the nature of developmental disorders involving speech and language impairments (Bishop et al. 2007; Bishop 2007) .
Mechanisms of Auditory Change Detection
This review has focused primarily on literature that has used the MMN measure to understand disorders of cognition and language. However, to fully explain the nature of an auditory processing deficit it is also important to understand the mechanisms of sound encoding, representation, and change detection that underlie behavioral perception. A more complete understanding of the neural processes that lead to the MMN, thus, is a necessary link in the chain. It is beyond the scope of this review to provide a full discussion of the debate surrounding the neural mechanisms underlying MMN (e.g., May and Tiitinen 2010; Bendixen et al. 2012; Fishman 2013 ). However, we note a number of important questions that need to be addressed in future studies.
Issues related to the underlying mechanisms contributing to the MMN response, such as whether MMN indexes neural adaptation (e.g., May and Tiitinen 2010), or stimulus predictions (Friston 2005; Schröger et al. 2013) have not been completely resolved. Almost all of the clinical studies reviewed above have focused on processing simple sensory stimulation. Although the simplest approach is often desirable, especially when assessing states of disorder, the use of more complex stimulation may reveal information not otherwise obtained, such as when trying to understand what breaks down for those who have difficulty hearing speech in noise. It is possible that the use of MMN with more complex auditory patterns will be enlightening in populations with language-related deficits (e.g., SLI, dyslexia, and central auditory processing disorders). For example, Bonte et al. (2007) found that children with dyslexia, unlike typical-reading children, did not show modulation of MMN amplitude in relation to the phonotactic probability of speech sounds in nonsense words. Examining change-detection in the context of more complex stimulus patterns is likely to enhance our understanding of auditory learning. For example, processing of tone features may be spared, or even enhanced in a particular disorder (e.g., ASD), where the process of learning sound patterns (e.g., phonotactic, syntactic patterns) is disordered.
It will also be important to further explore the role of NMDA receptor functioning in the deviance-detection process indexed by MMN. At least, studies of patients with Schizophrenia (e.g., Olney and Farber 1995; Coyle 2006) , stroke (e.g., Dhawan et al. 2010) , and normal aging (e.g., Magnusson et al. 2010 ) have linked impaired NMDA receptors to reduced amplitude MMN. This may be indicative of a wider distributed network in cortex (Kohlmetz et al. 2001 ) affecting learning and memory more generally. Specifically, an NMDA-receptor dysfunction may affect cognition in several different ways (Herrero et al. 2013) , playing a critical role in the initiation of longterm and working memory (Javitt et al. 1996; Newcomer et al. 1998) , and in plastic changes in the brain (Gu 2002; Heekeren et al. 2008; Stephan et al. 2006) . Clearly, deficient NMDA receptor functioning would have wide-ranging effects on cognitive function that go well beyond the auditory system. In this sense, poor MMN responses would simply be a reflection of this extensive breakdown. This possibility does not diminish findings that MMN can serve as a marker of risk for disorder (as has been found for psychosis, Perez et al. 2014a, b) . A clearer understanding of the processes underlying deviance-detection will allow a better understanding of the causal relationships among the various factors associated with a clinical disorder.
Conclusion
This review provided a brief overview of clinical research that has used the MMN measure to help elucidate the nature of auditory processing in these various disorders, as well as demonstrating the use of MMN as a measure to assess treatment protocols, as a marker for risk of symptoms (e.g., psychosis in schizophrenia), or disorder (e.g., language delay or dyslexia). Future research should consider the use of more complex stimulus paradigms to allow a more detailed understanding of auditory and speech deficits. The recent increase in studies aimed at understanding neural mechanisms underlying MMN elicitation, and the role of NMDA receptor functioning in these processes is an exciting and potentially fruitful area of inquiry, which has tremendous potential for improving the use of MMN as tool for clinical investigation. 
